|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Interest income earned on investments held in Trust Account | ||
| Changes in fair value of warrant liabilities | ||
| Changes in operating assets and liabilities: | ||
| Other current assets | ||
| Due to a related party | ||
| Accrued expenses and other payable | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Purchase of investments held in Trust Account | ||
| Redemption of investment held in Trust Account | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of public units in Public Offering | ||
| Proceeds from sale of private placement units | ||
| Proceeds from related parties | ||
| Repayment of promissory note to a related party | ||
| Payment of redemption of public shares | ||
| Repayment of promissory notes to a related party | ||
| Payment of underwriting commission | ||
| Payment of offering costs | ||
| Deposits received from a target company for business combination | ||
| Net cash (used in) provided by financing activities | ||
| Net change in cash | ||
| Cash at beginning of year | ||
| Cash at end of year | ||
| Supplemental disclosure of non-cash financing activities: | ||
| Deferred underwriting’ commission fees payable | ||
| Accretion of carrying value to redemption value of redeemable ordinary shares | ||
| Cash in transit to Trust Account |
Loading...
